Expression profiling of plac1 in murine cancer cell lines
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12743Keywords:
cancer, cell line, expression, immortalization, plac1Abstract
Summary. Aim: Placenta-specific 1 (PLAC1) is among recently-discovered placental antigens which exerts fundamental role in placental function and development. Increasing body of literature shows that PLAC1 is frequently activated and expressed in a wide variety of human cancers and promote cancer progression. However, no data is available regarding the expression of mouse orthologue, plac1, in murine cancer cell lines. Materials and Methods: We investigated the expression of plac1 in a series of murine cell lines from different histological origins, mammary carcinoma (4T1), melanoma (B16F10), colorectal carcinoma (CT26), renal carcinoma (Renca), glioma (GL26), B-cell lymphoma (A20 and BCL1) and also two fibroblast cell lines (NIH3T3 and L929), using RT-PCR, Western blotting and flow cytometry. Results: Our data demonstrated that plac1 transcript and plac1 protein were expressed in all examined cell lines, as judged by RT-PCR and Western blot, respectively. The molecular weight of mouse plac1 was experimentally observed to be approximately 24 kD. Flow cytometric analysis showed surface expression of plac1 in aforesaid cell lines ranging from 2% to 42.5%. Conclusion: Based on the ubiquitous expression of plac1, the investigated cancer cell lines or immortalized cell lines can be used to examine the role of plac1 in the process of immortalization.
References
Hanahan D, Weinberg Robert A. Hallmarks of cancer: the next generation. Cell 2011; 144: 646–74.
Ward JP, Gubin MM, Schreiber RD. The role of neoantigens in naturally occurring and therapeutically induced immune responses to cancer. Adv Immunol 2016; 130: 25–74.
Gubin MM, Artyomov MN, Mardis ER, et al. Tumor neoantigens: building a framework for personalized cancer immunotherapy. J Clin Invest 2015; 125: 3413–21.
Coulie PG, Van den Eynde BJ, van der Bruggen P, et al. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat Rev Cancer 2014; 14: 135–46.
Simpson AJ, Caballero OL, Jungbluth A, et al. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5: 615–25.
Salmaninejad A, Zamani MR, Pourvahedi M, et al. Cancer/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers. Immunol Invest 2016; 45: 619–40.
Cocchia M, Huber R, Pantano S, et al. PLAC1, an Xq26 gene with placenta-specific expression. Genomics 2000; 68: 305–12.
Chen Y, Moradin A, Schlessinger D, et al. RXRalpha and LXR activate two promoters in placenta- and tumor-specific expression of PLAC1. Placenta 2011; 32: 877–84.
Devor EJ, Leslie KK. The oncoplacental gene placenta-specific protein 1 is highly expressed in endometrial tumors and cell lines. Obstet Gynecol Int 2013; 2013: 807849.
Devor EJ, Reyes HD, Santillan DA, et al. Placenta-specific protein 1: a potential key to many oncofetal-placental OB/GYN research questions. Obstet Gynecol Int 2014; 2014: 678984.
Koslowski M, Sahin U, Mitnacht-Kraus R, et al. A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. Cancer Res 2007; 67: 9528–34.
Silva WA Jr, Gnjatic S, Ritter E, et al. PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses. Cancer Immun 2007; 7: 18.
Wang X, Baddoo MC, Yin Q. The placental specific gene, PLAC1, is induced by the Epstein-Barr virus and is expressed in human tumor cells. Virol J 2014; 11: 107.
Dong XY, Peng JR, Ye YJ, et al. Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients. Int J Cancer 2008; 122: 2038–43.
Wu Y, Lin X, Di X, et al. Oncogenic function of Plac1 on the proliferation and metastasis in hepatocellular carcinoma cells. Oncol Rep 2017; 37: 465–73.
Liu FF, Dong XY, Pang XW, et al. The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients. Gastroenterology 2008; 134: 998–1006.
Shantha Kumara HM, Grieco MJ, Caballero OL, et al. MAGE-A3 is highly expressed in a subset of colorectal cancer patients. Cancer Immun 2012; 12: 16.
Liu F, Zhang H, Shen D, et al. Identification of two new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1/CP1. J Gastroenterol 2013; 49: 419–26.
Chen J, Pang XW, Liu FF, et al. PLAC1/CP1 gene expression and autologous humoral immunity in gastric cancer patients. Beijing Da Xue Xue Bao 2006; 38: 124–7 (in Chinese).
Liu F, Shen D, Kang X, et al. New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma. J Clin Pathol 2015; 68: 913–6.
Tchabo NE, Mhawech-Fauceglia P, Caballero OL, et al. Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer. Cancer Immun 2009; 9: 6.
Devor EJ, Gonzalez-Bosquet J, Warrier A, et al. p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers. Int J Oncol 2017; 50: 1721–8.
Devor EJ, Reyes HD, Gonzalez-Bosquet J, et al. Placenta-specific protein 1 expression in human papillomavirus 16/18-positive cervical cancers Is associated with tumor histology. Int J Gynecol Cancer 2017; 27: 784–90.
Ghods R, Ghahremani MH, Darzi M, et al. Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta-specific 1. Biotechnol Appl Biochem 2014; 61: 363–9.
Ghods R, Ghahremani MH, Madjd Z, et al. High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma. Cancer Immunol Immunother 2014; 63: 1319–27.
Nejadmoghaddam MR, Zarnani AH, Ghahremanzadeh R, et al. Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy. Sci Rep 2017; 7: 13373.
Akhavan A, Ghods R, Jeddi-Tehrani M, et al. Production and purification of anti-rhombomys opimus immunoglobulins. Iran J Arthropod Borne Dis 2011; 5: 69–76.
Amini N, Vishteh MN, Zarei O, et al. Production and characterization of polyclonal antibody against a synthetic peptide from beta-actin protein. Iran J Basic Med Sci 2014; 17: 396–400.
Nazari M, Zarnani AH, Ghods R, et al. Optimized protocol for soluble prokaryotic expression, purification and structural analysis of human placenta specific-1 (PLAC1). Protein Expr Purif 2017; 133: 139–51.
Fant M, Barerra-Saldana H, Dubinsky W, et al. PLAC1 protein localizes to membranous compartments in the apical region of the syncytiotrophoblast. Mol Reprod Dev 2007; 74: 922–9.
Massabbal E, Parveen S, Weisoly DL, et al. PLAC1 expression increases during trophoblast differentiation: evidence for regulatory interactions with the fibroblast growth factor-7 (FGF-7) axis. Mol Reprod Dev 2005; 71: 299–304.
Yin Y, Zhu X, Huang S, et al. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. Tumour Biol 2017; 39: 1010428317699131.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
